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Kang X, Petyaykina K, Tao R, Xiong X, Dong XC, Liangpun-
sakul S. The inhibitory effect of ethanol on Sestrin3 in the pathogen-
esis of ethanol-induced liver injury. Am J Physiol Gastrointest Liver
Physiol 307: G58–G65, 2014. First published May 15, 2014;
doi:10.1152/ajpgi.00373.2013.—Sestrins (Sesns) are a family of
stress-sensitive genes that have been suggested to regulate lipid
metabolism. Chronic ethanol feeding is known to cause lipid accu-
mulation in hepatocytes. This study was designed to investigate the
role of Sesn3 in the pathogenesis of alcohol-induced hepatic steatosis.
We demonstrated that ethanol inhibited the expression of Sesn3 in
VL-17A cells. Overexpression of Sesn3 ameliorated triglyceride ac-
cumulation; downregulation using short hairpin RNA significantly
deteriorated triglyceride accumulation in these cells. The expression
of Sesn3 was also reduced in mice fed with ethanol for 4 wk.
Overexpression of Sesn3 prevented hepatic steatosis, whereas knock-
down of Sesn3 worsened hepatic steatosis in ethanol-fed mice. Over-
expression of Sesn3 significantly reduced the expression of genes
encoding for lipid synthesis through AMPK pathway. Overexpression
of Sesn3 augmented the effect of ethanol on phospho-p70 S6 kinase.
The levels of hepatic light chain 3, a marker for autophagy, expression
were significantly decreased in ethanol-fed mice after Sesn3 gene was
knocked down. Our findings suggest that inhibitory effect of ethanol
on Sesn3 may play an important role in the development of ethanol-
induced fatty liver.
Sestrin3; alcohol; steatosis
ALCOHOL-INDUCED HEPATIC STEATOSIS is characterized by fat ac-
cumulation in the liver in response to excessive alcohol con-
sumption (7, 22). Once considered as a benign condition, it is
now known that the presence of hepatic steatosis can lead to
advance clinical presentations such as steatohepatitis, ad-
vanced fibrosis, and eventually cirrhosis (21). The pathogene-
sis of alcoholic steatosis is complex, as multiple pathways are
involved, including the synthesis, export, and oxidation of
intrahepatic lipids (7).
Sestrins (Sesns) are a small family of stress-sensitive genes
that are conserved across several species, including C. elegans,
Drosophila melanogaster, and mammals (3, 13). Lower organ-
isms, such as worms and fruit flies, have only one Sesns gene;
however, three Sesns genes (Sesn1/2/3) have been identified in
mammals. Sesns are under the regulation of p53 and involved
in the control of cell growth and DNA damage secondary to
external stress stimuli (2, 9). Furthermore, Sesns were shown to
be negative regulators of mTOR (mechanistic target of rapa-
mycin) signaling through the activation of AMPK (AMP-
activated protein kinase) and tuberous sclerosis complex 2
phosphorylation (2, 3, 9, 13, 14).
Sesns have been shown to regulate several physiological
pathways, including lipid metabolism. dSesn (Drosophila or-
tholog of Sestrin)-deficient fruit flies accumulate more lipid
droplets in their fat bodies, equivalent to liver in mammals. The
mechanism involves a negative feedback regulation of Dro-
sophila target of target of rapamycin (dTOR) through Sestrin-
induced AMPK activation (13). Feeding dSesn-null mutants
with AMPK activators, such as 5-aminoimidazole-4-carbox-
amide 1--D-ribofuranoside or metformin, or the mTOR inhib-
itor rapamycin reduced triglyceride (TG) accumulation (13).
Additionally, the expression of the gene encoding transcription
factor sterol response element binding protein and its target,
such as fatty acyl coenzyme A synthase or fatty acid synthase,
was significantly increased in dSesn-null mutants (13).
The role of Sesn2 and Sesn3 on metabolic homeostasis has
been confirmed recently (14). Sesn2 ablation exacerbates obe-
sity-induced mTORC1-S6K activation, glucose intolerance,
insulin resistance, and hepatic steatosis, all of which are im-
proved by AMPK activation (14). Furthermore, concomitant
ablation of Sesn2 and Sesn3 provokes hepatic mTORC1-S6K
activation and insulin resistance, even in the absence of nutri-
tional overload and obesity. These results demonstrate an
important homeostatic function of Sesn in the control of mam-
malian lipid and glucose metabolism (14).
Chronic alcohol feeding leads to the alteration in intrahe-
patic lipid synthesis through regulation of lipogenic genes (21),
which are also under the regulation of dSesn in Drosophila
(13). Because of the role of Sesn3 in lipid metabolism, the
present study was designed to investigate the role of Sesn3 in
the pathogenesis of alcohol-induced hepatic steatosis.
MATERIAL AND METHODS
Cell line. The in vitro experiments were performed in the VL-17A
cells (a kind gift from Dr. Dahn Clemens, University of Nebraska), the
recombinant HepG2 cell line exhibiting alcohol dehydrogenase
(ADH) and cytochrome P-450 2E1 specific activities (6). The VL-
17A cells were cultured in Dulbecco’s modified Eagle’s medium,
supplemented with 10% fetal bovine serum, 100 g/ml streptomycin,
and 63 g/ml (Invitrogen).
Adenovirus transduction. Adenovirus carrying green fluorescent
protein (GFP) and Sesn3 coding sequence were generated using the
pAdEasy system (Agilent). Adenovirus carrying GFP and Sesn3 short
hairpin RNA sequences were generated using the BLOCK-iT system
(Invitrogen), and their target sequences are the following: GFP,
5=-GCATCAAGGTGAACTTCAAGA-3=; Sesn3, 5=-GGAGAAGA-
ACATTTGCCAACA-3=. We used a multiplicity of infection (MOI)
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of 50 for overexpression and a MOI of 100 for the short hairpin RNA
knockdown experiments.
Animals. Six- to eight-week-old male C57BL/6J mice (The Jackson
Laboratory, Bar Harbor, ME) were fed the Lieber-DeCarli alcohol-
containing diet, as previously described (15, 16). Mice were housed
individually in a room with controlled temperature (20–22°C), hu-
midity (55–65%), and regular 12:12 light-dark cycle. Protein content
was at 18% of total calories. There were two dietary groups: 1) control
diet (fat comprising 10% of total calories, 6% from cocoa butter, and
4% from safflower oil, 72% of calories as carbohydrate); and
2) alcohol-containing diet [identical to the control diet but with
ethanol added to account for 27.5% of total calories and the caloric
equivalent of carbohydrate (maltose-dextrin) removed]. The feeding
was carried out for 4 wk. Ten days before the kill date, alcohol-fed
mice (n  5 in each group) were injected with GFP (AdGFP),
Sesn3-overexpressing adenoviruses (AdSesn3), shGFP, and shSesn3
through tailed vein injection. At the time of death, mice were anes-
thetized with isoflurane, and hepatic tissues were harvested.
The studies were approved by the Indiana University School of
Medicine Animal Care and Use Committee, Indiana University Bio-
safety Committee, and the Roudebush Veterans Affairs Animal Use
Subcommittee.
Hepatic histology, blood chemistry, and metabolic analysis. A part
of the sliced liver tissues was fixed in 10% formalin solution for
hematoxylin and eosin, and the presence of intrahepatic fat was
confirmed with oil red O staining. Lipids were extracted from total
cell lysates (for the in vitro experiment) and hepatic tissues using a
chloroform-methanol mix. TG measurements were carried out using
Wako L-type TG H assay (Wako Diagnostics, Richmond, VA). Serum
alanine aminotransferase (ALT) (catalog no. 752–100) was measured
using the kit from BioVision (Milpitas, CA).
Protein analysis. Hepatic tissues or cells were homogenized in the
lysis buffer (50 mm HEPES, pH 7.5, 150 mm NaCl, 10% glycerol, 1%
Triton X-100, 1.5 mm MgCl2, 1 mm EGTA, 10 mm sodium pyro-
phosphate, 100 mm sodium fluoride, and freshly added 100 m
sodium vanadate, 1 mm PMSF, 10 g/ml aprotinin, and 10 g/ml
leupeptin). Protein extracts were resolved by SDS-PAGE and trans-
ferred to a nitrocellulose membrane. Proteins were probed using the
following antibodies: phosphorylated (p)-AMPK, AMPK, p-S6K1,
S6K1, light chain 3 (LC3), p62, and actin (Cell Signaling Technology,
Danvers, MA), Sesn1, Sesn2, and Sesn3 (Abcam). Detection of
proteins was carried out by incubations with horseradish peroxidase-
conjugated secondary antibodies followed by enhanced chemilumi-
nescence detection reagents (Perkin Elmer, Waltham, MA).
Real-time RT-PCR. Total RNA was prepared using an Absolutely
RNA RT-PCR Miniprep kit (Stratagene, Cedar Creek, TX). Reverse
transcription of 1-g total RNA to cDNA was performed using the
StrataScript qPCR cDNA synthesis kit (Stratagene). Real-time quan-
titative polymerase chain reaction amplification was performed in a
Stratagene MX 3005P thermal cycler (La Jolla, CA) using RT2 SYBR
Green qPCR Master Mix. Primers for SYBR Green-based real-time
PCR were purchased from SuperArray Bioscience (Frederick, MD).
The relative amount of target mRNA was calculated using the com-
parative cycle threshold (Ct) method and normalizing each target gene
with Ct of housekeeping gene, GAPDH.
Statistical analysis. All data are presented as the mean  SD. All
data in this study were analyzed with SPSS16.0 (SPSS). The signif-
icance between two groups or paired samples was analyzed by
Student’s t-test. The differences of quantitative variables among
groups were analyzed by ANOVA. All statistical differences were
two-sided, and P  0.05 was considered statistically significant.
RESULTS
Ethanol inhibits the Sesn3 gene expression in VL-17A cells.
Recombinant HepG2 cells expressing ADH and CYP2E1 (VL-
17A cells) were used in this study. Several studies have shown
that VL-17A cells oxidized ethanol and generated acetalde-
hyde, the levels of which depended on the initial ethanol
concentration (6). Thus we investigated the expression of
Sesn3 in VL-17A cells in response to ethanol treatment.
VL-17A cells were serum starved for 16 h and then exposed
to ethanol at 25 mM, 50 mM, and 100 mM for 48 h. As shown
in Fig. 1, A and B, ethanol inhibited the expression of Sesn3 in
the dose-dependent fashion. There was a significant 40% and
60% reduction in the level of Sesn3 with the treatment of
ethanol at 50 and 100 mM, respectively, compared with con-
trols (Fig. 1, A and B). In addition, ethanol also inhibited the
phosphorylation of AMPK- on Thr172 by 30% (with ethanol
50 mM) and 40% (with 100 mM, Fig. 1, A and C). As per our
laboratory’s previous publications (15, 16), the ethanol con-
centration at 50 mM was used in the subsequent experiments.
Overexpression of Sesn3 reduces TG accumulation in VL-
17A cells exposed to ethanol. To determine whether the inhi-
bition of Sesn3 by ethanol might affect the cellular TG accu-
mulation in vitro, we first tested the ability of VL-17A cells to
accumulate TG after ethanol treatment. VL-17A cells were
treated with ethanol (25–100 mM) for 48 h and were harvested
for TG measurement. As shown in Fig. 1, D and E, ethanol 50
and 100 mM increased the TG accumulation in VL-17A cells
by 1.8- and 1.6-fold, respectively.
To assess the role of Sesn3 in ethanol-induced TG accumu-
lation, VL-17A cells were seeded onto six-well plates at the
concentration of 4  105 cells/well in the cultured medium
described above. Cells were switched to serum-free media,
infected with AdGFP and AdSesn3 adenoviruses at 50 MOIs
for overexpression and 100 MOIs for shGFP and shSesn3 for
knockdown, and gently rocked for 2 h. After the transduction,
cells were treated with ethanol at 50 mM for 48 h, and cells
were harvested for TG measurement.
To confirm the transfection efficiency, the levels of Sesn3
were determined. AdSesn3 increased the expression of Sesn3
in VL-17A by 11-fold (Fig. 1F), whereas shSesn3 decreased
the expression of Sesn3 in VL-17A by 1.8-fold (Fig. 1G). Both
endogenous and overexpressed Sesn3 proteins were observed
between 50 and 55 kDa, indicating that GFP might be cleaved
out from the recombinant protein (Fig. 1F). Intracellular TG in
AdGFP cells treated with ethanol was increased by 1.6-fold,
and overexpression of Sesn3 by AdSesn3 significantly reduced
TG accumulation in VL-17A cells exposed to ethanol (4.4 
0.4 g/mg protein vs. 6.3 0.4 g/mg protein, P 0.05) (Fig.
1H). Knocking down Sesn3 by shSesn3 led to the increase in
intracellular TG by 1.5-fold compared with controls trans-
fected with shGFP (Fig. 1H). Likewise, ethanol treatment
increased the levels of cellular TG in shGFP-treated cells by
1.4-fold. shSesn3 significantly worsened TG accumulation in
VL-17A cells exposed to ethanol compared with controls (8.0 
0.8 vs. 4.1  0.4 g/mg protein, P  0.05, Fig. 1H). Taken
together, our results confirmed the role of Sesn3 in ethanol-
induced lipid accumulation.
Ethanol suppresses hepatic Sestrins expression in mice
chronically fed with ethanol. We next determined whether the
effects of ethanol observed in vitro also took place in vivo
using liver samples from our laboratory’s previously published
study from controls and pair-fed mice with Lieber Dicarli
Diet (15). As shown in our previous publications, these mice
developed hepatic steatosis after they were fed with ethanol-
containing diet for 4 wk (15, 16). Mouse liver expressed all
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three Sesn family members, with Sesn3 being the most
abundant Sestrin (data not shown). Ethanol feeding mark-
edly decreased the total mRNA expression of all three
Sestrins; however, its effect was most pronounced on Sesn3
(	2-fold for Sesn1, 2.5 -fold for Sesn2, and 	5-fold for
Sesn3) (Fig. 2, A and B).
Effect of overexpression and knockdown of Sesn3 on etha-
nol-induced hepatic steatosis in vivo. To further study the roles
of Sesn3 and ethanol-induced hepatic steatosis in vivo, we used
both gain-of-function and loss-of-function-based approaches
by injecting AdSesn3 and shSesn3, respectively, into mice.
Six- to eight-week-old male C57BL/6J mice were fed with the
Lieber-DeCarli alcohol-containing diet for 4 wk. Ten days
before death, ethanol-fed mice (n  5 in each group) were
injected with GFP (AdGFP), Sesn3-overexpressing adenovi-
ruses (AdSesn3), shGFP, and shSesn3 through tail vein injec-
tion.
Ethanol feeding inhibited hepatic Sesn3 protein expression
in mice injected with AdGFP and shGFP compared with
controls by approximately twofold (Fig. 3A). AdSesn3 injec-
tion overcame the effect of ethanol on Sesn3 by increasing
hepatic expression of Sesn3 by 5.5-fold compared with con-
trols and 	11-fold compared with ethanol-fed mice injected
with AdGFP. Injection of shSesn3 in mice fed with ethanol
significantly reduced hepatic Sesn3 expression by 3.3-fold
(compared to controls) and 1.7-fold (compared to mice injected
with shGFP) (Fig. 3A).
Alteration of hepatic Sesn3 with AdSesn3 and shSesn3
injection affected ethanol-induced hepatic steatosis. As shown
in Fig. 3B, overexpression of Sesn3 using AdSesn3 prevented
hepatic steatosis, whereas knockdown of Sesn3 with shSesn3
significantly worsened hepatic steatosis in mice fed with eth-
anol. We observed the levels of serum ALT were elevated in
ethanol-fed mice (injected with AdGFP and shGFP) compared
with controls. Although hepatic steatosis was significantly
improved with AdSesn3 injection, interestingly, we did not
observe the differences in the levels of serum ALT compared
wit that in ethanol-fed mice injected with AdGFP. On the other
Fig. 1. Effect of ethanol treatment on Sestrin3 (Sesn3) and AMP-activated protein kinase (AMPK) phosphorylation in VL-17A cells. Immunoblot analysis of
proteins in VL-17A cells treated with different concentrations of ethanol for 48 h is shown. The immunoblot bands (A) were quantified by densitometry analysis,
and the ratio of Sesn3 to -actin (B) and phosphorylated (p)-AMPK- to AMPK- (C) were calculated by setting the value of controls as one. Ethanol treatment
inhibited the expression of Sesn3 and AMPK- phosphorylation in the VL-17A cells in a dose-dependent manner. Results are means  SD (the blot is a
representative of 3 blots from 3 individual experiments). Significant differences among group were determined by one-way ANOVA. *P  0.05, significant
difference vs. control. Accumulation of triglyceride (TG) in VL-17A cells after ethanol treatment is shown. The presence of TG was confirmed by Oil Red O
staining (D), as well as TG measurement (E). VL-17A cells were transduced with control vectors [AdGFP (green fluorescent protein) or shGFP], AdSesn3 (F)
and shSesn3 (G). H: overexpression of Sesn3 ameliorated TG accumulation in VL-17A cells exposed to ethanol (E). Values are means  SD. *P  0.05,
significant difference vs. respective vector controls.
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hand, the serum ALT levels in ethanol-fed mice injected with
ShSens3 were significantly higher (60.4  7.3 mU/ml) than
those in controls and in ethanol-fed mice injected with shGFP
(Fig. 3, C and D).
Biochemical analysis by measurement of hepatic TG con-
firmed that ethanol increased hepatic TG accumulation in mice
injected with AdGFP and shGFP compared with controls (Fig.
3, E and F). Overexpression of Sesn3 significantly reduced
hepatic TG concentrations in mice fed with ethanol compared
with those injected with AdGFP by 1.4-fold. Knocking down
Sesn3 by shSesn3 significantly increased hepatic TG concen-
trations in ethanol-fed mice by almost 4-fold (compared with
pair fed controls) and 1.8-fold (compared with ethanol-fed
mice injected with shGFP). Morphological examination of the
hepatic tissues showed the increase in liver-to-body weight
ratio in ethanol-fed mice compared with controls (Fig. 3, G and
H). However, ethanol-fed mice injected with shSesn3 had the
highest liver-to-body weight ratio compatible with the degree
of hepatic steatosis as shown by Oil Red O staining and TG
measurements (Fig. 3H).
Effects of overexpression and knockdown of Sesn3 on the
AMPK signaling pathway and expression of genes involved in
fatty acid synthesis and oxidation in mice fed with ethanol.
Sesn3 has been shown to activate AMPK (13, 14). We, there-
fore, further explored the role of Sesn3 on the AMPK signaling
pathway in ethanol-fed mice. As shown in Fig. 4A, ethanol
significantly inhibited the phosphorylation of AMPK-, indi-
cated by a reduction in hepatic p-AMPK--to-AMPK- ratio
in mice injected with either AdGFP or shGFP. Overexpression
of Sesn3 with AdSesn3 significantly abrogated the effect of
ethanol on AMPK phosphorylation, and it increased the ex-
pression of p-AMPK--to-AMPK- ratio by 1.5-fold (com-
pared with control) and 2-fold (compared with AdGFP-injected
mice fed with ethanol) (Fig. 4B). The effect of ethanol on
AMPK phosphorylation was augmented by knocking down
Sesn3 with shSesn3 (Fig. 4, A and C). Knocking down Sesn3
led to the reduction of p-AMPK--to-AMPK- ratio by
1.6-fold compared with shGFP-injected mice fed with eth-
anol (Fig. 4C).
We next determined the effect of overexpression and knock-
down of Sesn3 on the mRNA expression of genes encoding for
fatty acid oxidation or synthesis in ethanol-fed mice. As shown
in Fig. 4, D and G, ethanol feeding increased mRNA expres-
sion of lipogenic enzymes (fatty acid synthase, and acetyl-CoA
carboxylase) and inhibited expression of genes involved in
fatty acid oxidation (peroxisome proliferator-activated recep-
tor-
 coactivator-1 and peroxisome proliferator-activated re-
ceptor-). Overexpression of Sesn3 reversed the ethanol effect,
as it significantly reduced the expression of genes encoding for
lipid synthesis and increased the levels of mRNA involved in
fatty acid oxidation. Conversely, knocking down Sesn3 by
shSesn3 worsened the effect of ethanol on the mRNA expres-
sion levels of these genes. Taken together, our findings sug-
gested that Sesn3 regulated genes involved in hepatic lipid
metabolism in ethanol fed mice.
Impacts of overexpression or knockdown of Sesn3 on the
mTOR signaling and autophagy pathway in mice fed with
ethanol. Previous reports have showed that upregulation of
Sesn3 downregulates mTOR, a major regulatory pathway sup-
pressing the activation of autophagy (2, 3, 9, 13, 14). We thus
determined the effect of overexpression and knockdown of
Sesn3 on mTOR signaling and autophagy pathway in mice fed
with ethanol.
Chronic ethanol feeding for 4 wk in mice injected with either
AdGFP or shGFP led to the inactivation of mTOR (	1.3- to
	1.4-fold compared with controls), as manifested by decreas-
ing in phosphorylation of p70 S6 kinase, a major downstream
target of mTOR. Overexpression of Sesn3 augmented the
effect of ethanol on phospho-p70 S6 kinase by suppressing the
expression of phospho-p70 S6K protein by 1.7- and 1.4-fold,
compared with pair-fed controls and ethanol-fed mice injected
with AdGFP, respectively (Fig. 5, A and B). On the other hand,
knockdown of Sesn3 using shSesn3 reversed the effect of
ethanol on mTOR, indicated by the increase in phospho-p70
S6K in ethanol-fed mice injected with shSesn3 by 1.2- and
1.75-fold compared with controls and ethanol-fed mice in-
jected with shGFP, respectively (Fig. 5, A and B).
Next we determined the effects of overexpression and
knockdown Sesn3 on the expression of microtubule-associated
protein 1 LC3 in ethanol-fed mice. LC3, commonly used as a
marker for autophagy, has two forms: LC3-I and LC3-II. When
autophagy is activated, cytosolic LC3-I is converted to mem-
brane-bound lapidated LC3-II. We found that the levels of
LC-II were increased by 	1.5-fold in mice chronically fed
with ethanol (Fig. 5, A and B), suggesting the induction of
autophagy in ethanol-fed mice. Overexpression of Sesn3 using
adenovirus increased the levels of hepatic LC3-II by 1.9-fold
(compared with controls) and 1.2-fold (compared with mice
Fig. 2. Ethanol inhibits hepatic Sesn expres-
sion. A: Sesn mRNA was analyzed from the
hepatic tissues in mice fed with ethanol (E)
for 4 wk compared with pair-fed controls.
Ethanol’s effect was most pronounced on
Sesn3. B: chronic ethanol feeding signifi-
cantly reduced protein expression of all three
Sestrins, particularly on Sesn3. Data were
analyzed from controls and ethanol-fed mice
(n  3 in each group). *Significance with
P  0.05 compared with controls. LF, low
fat.
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fed with ethanol). On the other hand, suppression of Sesn3 with
shSesn3 significantly decreased the levels of hepatic LC3-II by
2-fold compared with controls and by 2.4-fold compared with
ethanol-fed mice (Fig. 5, A and B).
To confirm the findings in vivo and more accurately monitor
autophagic flux, we treated VL-17A cells transfected with
AdSesn3 and shSesn3 in the absence or presence of chloro-
quine (25 M), which modifies lysosomal pH, and thus inhibits
autophagy flux through lysosomes. We performed additional
analysis of autophagy using two commonly used markers,
p62/Sqstm1 (sequestosome 1) and LC3-II. The p62 protein is
involved in chaperone-mediated protein degradation. During
autophagy, the amount of p62 is inversely correlated with
cellular autophagic activity (11). Overexpression of Sesn3 by
AdSens3 increased the amount of LC3-II by 1.5-fold, while the
expression of p62 was reduced by almost 2-fold, suggesting the
increase in autophagic activity with the overexpression of
Sesn3. Ethanol increased the levels of LC3-II by 1.3-fold, and
the levels of LC3-II was further increased (by 1.8-fold com-
pared with controls and 1.3-fold compared with ethanol-treated
cells) when we overexpressed Sesn3 in the VL-17A cells. In
the loss of function experiments, suppression of Sesn3 led to
the reduction in LC3-II expression by 1.7-fold. While ethanol
treatment in VL-17A cells transfected with shGFP caused the
increase in LC3-II levels by 1.2-fold, suppression of Sesn3 in
the presence of ethanol decreased the expression of LC3-II by
2.8-fold. Similar observations were observed when the exper-
iments were performed with the presence of chloroquine.
Furthermore, the expression of p62 was inversely correlated
with the expression of LC3-II (Fig. 5, C–F).
DISCUSSION
In this study, we observed that ethanol treatment in cultured
cells and chronic ethanol feeding in mice significantly reduced
hepatic Sesn3 expression. Overexpression of Sesn3 improved
the effect of ethanol on TG accumulation in VL-17A cells
and mouse livers. On the other hand, in the loss-of-function
Fig. 3. Effect of overexpression and knockdown of Sesn3 on ethanol (ETOH)-induced hepatic steatosis in vivo. A: hepatic Sesn3 expression from mice in each
group. B: histology [hematoxylin and eosin (H&E) and Oil Red O stain of hepatic tissues in controls (C) and mice fed with ethanol]. Ethanol feeding caused
hepatic steatosis. Overexpression of Sesn3 using AdSesn3 prevented ethanol-induced hepatic steatosis, and knockdown of Sesn3 with shSesn3 significantly
worsened hepatic steatosis in mice fed with ethanol. C and D: serum alanine aminotransferase (ALT) levels in controls and ethanol-fed mice injected with AdGFP
and AdSesn3 (C) and shGFP and shSesn3 (D). E and F: hepatic triglyceride measurements in controls and ethanol-fed mice injected with AdGFP and AdSesn3
(E) and shGFP and and shSesn3 (F). Overexpression of Sesn3 significantly reduced hepatic TG concentrations in mice fed with ethanol. G and H: liver and body
weight ratio from each experimental group. Ethanol-fed mice injected with shSesn3 had the highest liver-to-body weight ratio. *P  0.05, significant difference
compared with controls. $P  0.05 vs. respective vector controls.
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experiments, knockdown of Sesn3 worsened the effect of
ethanol by promoting fat accumulation in VL-17A cells and the
liver of mice fed with ethanol. The role of Sesn3 in ethanol-
induced hepatic steatosis is likely mediated in part through
AMPK signaling that leads to the alteration in the set of genes
involving in fatty acid oxidation and synthesis.
Sestrins are involved in complex regulation of cell viability
in response to various external stimuli causing cellular injury
(3). Sestrins maintain metabolic homeostasis by suppressing
mTOR activity (2, 4, 13). Sestrins can bring an upstream
kinase liver kinase B1 (LKB1) and regulatory AMPK- and
AMPK-
 subunits to the catalytic AMPK- subunit, thereby
facilitating LKB1-dependent activator Thr172 phosphorylation
of AMPK- (19). Through regulation of the AMPK-mTORC1
signaling axis, Sestrins promote metabolic adaptation of cells
and regulate cellular and lipid metabolism (8). In Drosophila,
loss of dSesn causes moderate downregulation of AMPK and
upregulation of dTORC1 in the fat body, thus leading to
increased expression of mRNAs encoding lipogenic enzymes,
ultimately resulting in TG accumulation. Interestingly, this
excessive fat accumulation can be suppressed by pharmaco-
logical activation of AMPK and inhibition of dTORC1 (12).
In our study, we found the important role of Sesn3 in the
pathogenesis of alcoholic steatosis. We found that ethanol can
downregulate Sesn3 at both mRNA and protein levels. Over-
expression of Sesn3 overcame the effect of ethanol on hepatic
steatosis, likely through the activation of AMPK-, which led
to the inhibition of fatty acid synthesis and activation of fatty
acid oxidation. By contrast, knockdown of Sesn3 led to the
inhibition of AMPK- and deteriorates the degree of hepatic
steatosis in mice fed with ethanol. In our experiments, we also
observed the elevation of ALT in the liver of ethanol-fed mice.
In general, the ethanol feeding protocol that we used rarely
caused significant hepatic inflammation, as indicated by min-
imal or no inflammatory cells infiltration in the hematoxylin
and eosin staining. We suspected that the elevation in ALT was
the surrogate for the presence of hepatic steatosis. In fact,
elevation of ALT was observed in human subjects with hepatic
steasosis in the absence of steatohepatitis (10, 20). Interest-
ingly, we found significant increase in serum ALT in ethanol-
fed mice injected with shSesn3, parallel with worsening he-
patic steatosis in these mice.
Sestrins are a family of highly conserved stress-responsive
proteins. Ethanol is known to generate intracellular oxidative
stress; however, we, in fact, found the inhibition of Sesn3 by
ethanol. Our results are not surprising as each Sesns gene might
be regulated differently. For instance, Sesn2 can be induced by
starvation, and high-fat diet (HFD) (1, 2, 14). On the other
Fig. 4. Overexpression and knockdown of Sesn3 affect the AMPK signaling pathway in mice fed with ethanol. A: Western blotting of p-AMPK- proteins in
controls, AdGFP-, shGFP-, AdSesn3-, and shSesn3-injected mice. Actin was used as the loading controls. B and C: bar graphs represented the immunoblot
analysis. Overexpression or knockdown Sesns3 also regulated expressions of genes encoding fatty acid synthesis (FAS) (D and E) and oxidation (F and G). ACC,
acetyl-CoA carboxylase; PGC-1, peroxisome proliferator-activated receptor-
 coactivator-1; PPAR-, peroxisome proliferator-activated receptor-. *P 
0.05, significant difference compared with controls. #,^P  0.05 vs. respective vector controls.
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hand, Sesn3 is not induced by high-fat diet in mouse liver or by
H2O2 (which generates oxidative stress) in human primary
myotubes (14, 18). Clearly, the mechanism on how ethanol
inhibits Sesn3 needs to be further evaluated.
Ethanol also affects autophagy via metabolic intermediates
and mTOR inhibition (5). Previous studies showed that the
induction of autophagy was only observed in ethanol-treated
VL-17A cells (which efficiently metabolized ethanol due to
overexpression of ADH and CYP2E1, similar to our findings),
but not in ethanol-treated HepG2 cells, which have a very weak
capability of metabolizing ethanol (5). The mTOR pathway is
a major pathway suppressing the activation of autophagy.
Ethanol caused a dose-dependent inhibition of mTOR, and its
effect was reversed with the inhibitor of ethanol metabolism
(5). Interesting, pharmacological promotion of autophagy with
carbamazepine or rapamycin reduced hepatic steatosis in eth-
anol-fed mice (17). In our study, overexpression of Sesn3 can
induce autophagy in hepatocytes, and its effect was likely
Fig. 5. Overexpression and knockdown of Sesn3 affect the mTOR signaling and autophagy pathway in mice fed with ethanol. A and B: effect of ethanol on p70
S6K, a major downstream target of mTOR and marker of autophagy [light chain 3 (LC3)] in mice liver was analyzed by Western blotting. C and F: to confirm
the findings in vivo, we performed autophagic flux assay using VL-17A cells, which were transfected with AdSesn3 and shSesn3 treated as indicated in the
presence or absence of chloroquine (CQ; 25 M). The immunoblot bands (C and D) were quantified by densitometry analysis, and the ratio of LC3-II (E) and
p62 (F) to -actin was calculated. *P  0.05, significant difference compared with controls. $P  0.05 vs. respective vector controls.
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through the inhibition of mTOR activity. The enhanced au-
tophagic activity could thus result in increased degradation of
lipid droplets, and thus improvement in hepatic steatosis,
which was observed in mice injected with AdSesn3. We
observed the opposite results with worsening hepatic steatosis
when we suppressed the expression of Sesn3 with shSesn3.
It is important to point out that the previous report did not
demonstrate significant hepatic steatosis in mice with concom-
itant loss of Sesn2 and Sesn3 (14). In our study, we found that
suppression of Sesn3 alone using shSesn3 in the presence of
ethanol led to significant hepatic steatosis. It is plausible that
the developmental loss of Sesn2/3 might have induced a certain
compensatory mechanism that overcomes or corrects the un-
derlying metabolic derangements in Sesn2/3 double knockout
mice. Perhaps such a mechanism did not take place in our
model when the expression of Sesn3 was temporarily silenced
with the introduction of adenovirus.
In summary, we have identified Sesn3 as a critical player in
the development of ethanol-induced fatty liver. Our data also
suggest that modulation of Sesn3 might be useful for the
prevention and treatment of alcoholic fatty liver disease.
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